Nature Reviews Neuroscience , 22(9), 541558
NT-proBNP is an established indicator of heart failure and cardiovascular stress with dynamic response to disease state and treatment [21,22,23], while IL-6 is a cytokine that is upstream of C-reactive protein and provides a complementary marker of systemic inflammation, which has been successfully targeted in the treatment of CVD [24]
Common benefits include increased mobility, improved self-esteem and self-confidence as well as the potential to reduce the need for medications that lower cholesterol and blood pressure
EVOKE+ nevertheless showed favorable shifts in Alzheimers-related biomarkers, indicating meaningful biological engagement and sharpening the fields focus toward earlier intervention, better patient selection, and improved brain delivery
How does the Carcinogenic Potency Categorization Approach (CPCA) assign AI limits to beta-lactam NDSRIs
Front Endocrinol 12:676133